Head louse infestations before and during the COVID-19 epidemic in Israel.
Head louse
Israel
Pediculicides
Pediculosis
Pediculus humanus capitis
Journal
Acta tropica
ISSN: 1873-6254
Titre abrégé: Acta Trop
Pays: Netherlands
ID NLM: 0370374
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
30
04
2022
accepted:
01
05
2022
pubmed:
26
5
2022
medline:
15
6
2022
entrez:
25
5
2022
Statut:
ppublish
Résumé
Head louse infestations caused by Pediculus humanus capitis (Phthiraptera: Pediculidae) are a public health problem in developing and developed countries worldwide. Head to head contact is by far the most common mode of lice transmission. In March 2020, WHO declared the COVID-19 outbreak as a pandemic. Starting from March 2020, the Israeli government established mandatory isolation for extensive periods including closure of school systems for very long time. The aim of the project was to compare the pediculicide sale numbers before the COVID-19 epidemic with those starting of the epidemic in 2020, as a possible marker for changing epidemiology of head lice during the COVID pandemic. Data were collected from a large pharmacy chain in Israel, which provided the actual sales of pediculicides during the years 2010-2020. During the period 2010-2019 a significant increase of pediculicide sales from 281,986 - 498,107 was observed, the highest number being from 2019. In 2020, this number dropped to 294,477, a significant drop compared to previous years and to 2019. The results of this study suggest that head louse infestations are increasing in the last years, while the extended isolation of children due to COVID-19 influenced significantly the infestation rate of children with head lice.
Identifiants
pubmed: 35613657
pii: S0001-706X(22)00195-4
doi: 10.1016/j.actatropica.2022.106503
pmc: PMC9124160
pii:
doi:
Substances chimiques
Insecticides
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
106503Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.
Références
Int J Dermatol. 1990 Sep;29(7):502-6
pubmed: 2228380
Int J Dermatol. 2021 Mar;60(3):272-280
pubmed: 32767380
Isr J Med Sci. 1991 Oct;27(10):562-5
pubmed: 1955310
Paediatr Drugs. 1999 Jul-Sep;1(3):211-8
pubmed: 10937452
Parasitol Res. 2021 Feb;120(2):443-450
pubmed: 33409635